

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.35664349 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.20869275 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.10952573 |
| 4 | vocalization behavior (GO:0071625) | 5.02510176 |
| 5 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.90655228 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.83310963 |
| 7 | protein localization to synapse (GO:0035418) | 4.81466141 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.51685949 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.51557156 |
| 10 | glutamate secretion (GO:0014047) | 4.48262130 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.47254117 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.44610052 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.41305085 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.33187538 |
| 15 | locomotory exploration behavior (GO:0035641) | 4.20555948 |
| 16 | neuron recognition (GO:0008038) | 4.17349114 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.12913959 |
| 18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.12697201 |
| 19 | glutamate receptor signaling pathway (GO:0007215) | 4.07158641 |
| 20 | presynaptic membrane assembly (GO:0097105) | 4.06292705 |
| 21 | nucleobase catabolic process (GO:0046113) | 4.05474662 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.04654664 |
| 23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.02328148 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 3.95382628 |
| 25 | postsynaptic membrane organization (GO:0001941) | 3.93603021 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 3.92209595 |
| 27 | exploration behavior (GO:0035640) | 3.89014122 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.87426782 |
| 29 | presynaptic membrane organization (GO:0097090) | 3.84279338 |
| 30 | axonal fasciculation (GO:0007413) | 3.79312062 |
| 31 | neurofilament cytoskeleton organization (GO:0060052) | 3.61578359 |
| 32 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.60624294 |
| 33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.54284056 |
| 34 | transmission of nerve impulse (GO:0019226) | 3.52418637 |
| 35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.48359430 |
| 36 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.48297469 |
| 37 | cell migration in hindbrain (GO:0021535) | 3.43491287 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.43466295 |
| 39 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.42863780 |
| 40 | layer formation in cerebral cortex (GO:0021819) | 3.39543734 |
| 41 | behavioral response to nicotine (GO:0035095) | 3.36627575 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.35386831 |
| 43 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.33894495 |
| 44 | neurotransmitter transport (GO:0006836) | 3.32439640 |
| 45 | gamma-aminobutyric acid transport (GO:0015812) | 3.32126502 |
| 46 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.30467840 |
| 47 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.29684178 |
| 48 | proline transport (GO:0015824) | 3.29630005 |
| 49 | regulation of synapse structural plasticity (GO:0051823) | 3.29476115 |
| 50 | regulation of postsynaptic membrane potential (GO:0060078) | 3.27386260 |
| 51 | regulation of neurotransmitter secretion (GO:0046928) | 3.26549568 |
| 52 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.26135578 |
| 53 | positive regulation of synapse maturation (GO:0090129) | 3.25480982 |
| 54 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.23803446 |
| 55 | positive regulation of synapse assembly (GO:0051965) | 3.21799941 |
| 56 | long-term memory (GO:0007616) | 3.19038230 |
| 57 | synaptic vesicle endocytosis (GO:0048488) | 3.17448974 |
| 58 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.14874617 |
| 59 | dendrite morphogenesis (GO:0048813) | 3.14759157 |
| 60 | regulation of vesicle fusion (GO:0031338) | 3.13495793 |
| 61 | dendritic spine morphogenesis (GO:0060997) | 3.13094150 |
| 62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.11561658 |
| 63 | synapse assembly (GO:0007416) | 3.11210595 |
| 64 | cerebellar granule cell differentiation (GO:0021707) | 3.10669216 |
| 65 | positive regulation of membrane potential (GO:0045838) | 3.08757737 |
| 66 | long-term synaptic potentiation (GO:0060291) | 3.08220665 |
| 67 | cellular potassium ion homeostasis (GO:0030007) | 3.07966403 |
| 68 | membrane depolarization during action potential (GO:0086010) | 3.05856169 |
| 69 | regulation of synaptic plasticity (GO:0048167) | 3.04703407 |
| 70 | regulation of glutamate secretion (GO:0014048) | 3.03659161 |
| 71 | startle response (GO:0001964) | 3.01941032 |
| 72 | regulation of neurotransmitter levels (GO:0001505) | 3.01589457 |
| 73 | innervation (GO:0060384) | 3.01512168 |
| 74 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.01472003 |
| 75 | serotonin metabolic process (GO:0042428) | 3.01008217 |
| 76 | regulation of neurotransmitter transport (GO:0051588) | 3.00959101 |
| 77 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.00955482 |
| 78 | negative regulation of microtubule polymerization (GO:0031115) | 3.00472301 |
| 79 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.98571380 |
| 80 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.96265285 |
| 81 | membrane depolarization (GO:0051899) | 2.95410218 |
| 82 | neuronal ion channel clustering (GO:0045161) | 2.95263543 |
| 83 | behavioral fear response (GO:0001662) | 2.94967882 |
| 84 | behavioral defense response (GO:0002209) | 2.94967882 |
| 85 | neuromuscular synaptic transmission (GO:0007274) | 2.94226929 |
| 86 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93402272 |
| 87 | response to histamine (GO:0034776) | 2.93287609 |
| 88 | dendrite development (GO:0016358) | 2.90410522 |
| 89 | adult walking behavior (GO:0007628) | 2.90198243 |
| 90 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.89708886 |
| 91 | protein localization to cilium (GO:0061512) | 2.89661787 |
| 92 | glycosphingolipid biosynthetic process (GO:0006688) | 2.89090906 |
| 93 | positive regulation of neurotransmitter transport (GO:0051590) | 2.88875356 |
| 94 | negative regulation of neurotransmitter transport (GO:0051589) | 2.88730992 |
| 95 | membrane hyperpolarization (GO:0060081) | 2.88693324 |
| 96 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.87609989 |
| 97 | neuronal action potential (GO:0019228) | 2.87135942 |
| 98 | auditory behavior (GO:0031223) | 2.86745622 |
| 99 | learning (GO:0007612) | 2.86568123 |
| 100 | fear response (GO:0042596) | 2.85799893 |
| 101 | synaptic transmission (GO:0007268) | 2.84882143 |
| 102 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.83550555 |
| 103 | regulation of respiratory system process (GO:0044065) | 2.82610710 |
| 104 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.79932698 |
| 105 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.79932698 |
| 106 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.79481018 |
| 107 | mitochondrion transport along microtubule (GO:0047497) | 2.79481018 |
| 108 | activation of protein kinase A activity (GO:0034199) | 2.78765181 |
| 109 | establishment of mitochondrion localization (GO:0051654) | 2.78355838 |
| 110 | mechanosensory behavior (GO:0007638) | 2.78338748 |
| 111 | calcium ion-dependent exocytosis (GO:0017156) | 2.78167395 |
| 112 | regulation of protein kinase A signaling (GO:0010738) | 2.77900220 |
| 113 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.77833659 |
| 114 | regulation of synaptic transmission (GO:0050804) | 2.76737954 |
| 115 | synapse organization (GO:0050808) | 2.76710509 |
| 116 | positive regulation of dendritic spine development (GO:0060999) | 2.76613454 |
| 117 | nonmotile primary cilium assembly (GO:0035058) | 2.76131943 |
| 118 | neuromuscular process controlling posture (GO:0050884) | 2.75647988 |
| 119 | response to auditory stimulus (GO:0010996) | 2.75517377 |
| 120 | mating behavior (GO:0007617) | 2.74738940 |
| 121 | retinal ganglion cell axon guidance (GO:0031290) | 2.74326490 |
| 122 | primary amino compound metabolic process (GO:1901160) | 2.72505333 |
| 123 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.67200916 |
| 124 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.65970009 |
| 125 | adult behavior (GO:0030534) | 2.64402732 |
| 126 | regulation of synapse assembly (GO:0051963) | 2.63667178 |
| 127 | behavioral response to cocaine (GO:0048148) | 2.63632360 |
| 128 | retinal cone cell development (GO:0046549) | 2.61286429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.26476744 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.92879247 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.02837011 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95935628 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.87741918 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57982353 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57982353 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55738850 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50892034 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50435683 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.50215240 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45380992 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41831429 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.39620535 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32512905 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29713511 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.29401084 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.22543639 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.13574529 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10343453 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06970974 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.06823741 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05825353 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.98460596 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.96062775 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.95473149 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.94915670 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.92633012 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92110490 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90997511 |
| 31 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.89835952 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.82647414 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76010422 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.75066262 |
| 35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.69643433 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66790054 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.65823356 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65377381 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63948579 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.55419698 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.54500314 |
| 42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51672478 |
| 43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.51410097 |
| 44 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.50447568 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49215980 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47495731 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47485804 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46463427 |
| 49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.46196384 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45856763 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44978656 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44423911 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44029663 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41831036 |
| 55 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.40636654 |
| 56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38651249 |
| 57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37528198 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35122292 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30989581 |
| 60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30964125 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30143837 |
| 62 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26582080 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24243093 |
| 64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24243093 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20502517 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19778543 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19430307 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.17885688 |
| 69 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17424876 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17400978 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17117906 |
| 72 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.16700405 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16196910 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15705597 |
| 75 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.15242349 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14433753 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13881328 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13061803 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12929121 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12491706 |
| 81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11447512 |
| 82 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10002648 |
| 83 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08938772 |
| 84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08539735 |
| 85 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08199043 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07890991 |
| 87 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06699969 |
| 88 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06664010 |
| 89 | JUN_21703547_ChIP-Seq_K562_Human | 1.06231099 |
| 90 | AR_19668381_ChIP-Seq_PC3_Human | 1.05888677 |
| 91 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05590916 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05265390 |
| 93 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05016958 |
| 94 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03903808 |
| 95 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03341734 |
| 96 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.02626107 |
| 97 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02614394 |
| 98 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99999582 |
| 99 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99584333 |
| 100 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99557860 |
| 101 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99455822 |
| 102 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99455822 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98911441 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97489957 |
| 105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97133115 |
| 106 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96717836 |
| 107 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94818183 |
| 108 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93453055 |
| 109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92757323 |
| 110 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.89804442 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89471315 |
| 112 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89180321 |
| 113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87750364 |
| 114 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87142764 |
| 115 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86716078 |
| 116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86571093 |
| 117 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.86306749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.03380580 |
| 2 | MP0003880_abnormal_central_pattern | 4.99732753 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.65350535 |
| 4 | MP0004270_analgesia | 3.56943624 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.27344716 |
| 6 | MP0009745_abnormal_behavioral_response | 3.10120590 |
| 7 | MP0009046_muscle_twitch | 2.99890769 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.97659901 |
| 9 | MP0002064_seizures | 2.93661440 |
| 10 | MP0002735_abnormal_chemical_nociception | 2.90657091 |
| 11 | MP0002736_abnormal_nociception_after | 2.77995659 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.74491854 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.66388590 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.65847689 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.57896640 |
| 16 | MP0002272_abnormal_nervous_system | 2.57762929 |
| 17 | MP0001486_abnormal_startle_reflex | 2.35149513 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.23346310 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.18998692 |
| 20 | MP0002822_catalepsy | 2.16505323 |
| 21 | * MP0000778_abnormal_nervous_system | 2.16003993 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.11831636 |
| 23 | MP0001970_abnormal_pain_threshold | 2.07286044 |
| 24 | MP0002184_abnormal_innervation | 2.06146630 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.91372266 |
| 26 | MP0003122_maternal_imprinting | 1.78543535 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.75408325 |
| 28 | MP0001529_abnormal_vocalization | 1.75142928 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.70828336 |
| 30 | MP0004924_abnormal_behavior | 1.70828336 |
| 31 | MP0003787_abnormal_imprinting | 1.68751363 |
| 32 | MP0008569_lethality_at_weaning | 1.67319804 |
| 33 | MP0001984_abnormal_olfaction | 1.65189569 |
| 34 | MP0004858_abnormal_nervous_system | 1.64872300 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.61823695 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.61683625 |
| 37 | MP0004142_abnormal_muscle_tone | 1.58955191 |
| 38 | * MP0000955_abnormal_spinal_cord | 1.58484549 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.55726814 |
| 40 | MP0002882_abnormal_neuron_morphology | 1.54649334 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.53475180 |
| 42 | MP0001188_hyperpigmentation | 1.53273219 |
| 43 | MP0003329_amyloid_beta_deposits | 1.51533233 |
| 44 | MP0001905_abnormal_dopamine_level | 1.50719809 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.44496043 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.39276312 |
| 47 | MP0004742_abnormal_vestibular_system | 1.26604759 |
| 48 | MP0003123_paternal_imprinting | 1.23460700 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.21873794 |
| 50 | MP0008789_abnormal_olfactory_epithelium | 1.19744298 |
| 51 | MP0004885_abnormal_endolymph | 1.19003447 |
| 52 | MP0000751_myopathy | 1.18571188 |
| 53 | MP0003879_abnormal_hair_cell | 1.18422826 |
| 54 | * MP0002152_abnormal_brain_morphology | 1.16177182 |
| 55 | MP0000566_synostosis | 1.14540457 |
| 56 | MP0005187_abnormal_penis_morphology | 1.13139118 |
| 57 | MP0003890_abnormal_embryonic-extraembry | 1.10225324 |
| 58 | MP0002229_neurodegeneration | 1.10175856 |
| 59 | MP0003633_abnormal_nervous_system | 1.08004758 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.06749121 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.06329569 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.04720049 |
| 63 | MP0002752_abnormal_somatic_nervous | 1.04115287 |
| 64 | MP0001963_abnormal_hearing_physiology | 1.02772606 |
| 65 | MP0003631_nervous_system_phenotype | 1.00559116 |
| 66 | MP0000631_abnormal_neuroendocrine_gland | 1.00524666 |
| 67 | MP0005171_absent_coat_pigmentation | 1.00292490 |
| 68 | MP0003634_abnormal_glial_cell | 0.99349877 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 0.98386314 |
| 70 | * MP0004133_heterotaxia | 0.96052598 |
| 71 | MP0005499_abnormal_olfactory_system | 0.90876583 |
| 72 | MP0005394_taste/olfaction_phenotype | 0.90876583 |
| 73 | MP0002751_abnormal_autonomic_nervous | 0.90844053 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 0.90803498 |
| 75 | MP0000920_abnormal_myelination | 0.89254575 |
| 76 | MP0003119_abnormal_digestive_system | 0.87059824 |
| 77 | MP0002638_abnormal_pupillary_reflex | 0.86567257 |
| 78 | MP0002102_abnormal_ear_morphology | 0.86336966 |
| 79 | MP0003938_abnormal_ear_development | 0.85728792 |
| 80 | MP0002069_abnormal_eating/drinking_beha | 0.85343285 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.85045088 |
| 82 | MP0005409_darkened_coat_color | 0.84908152 |
| 83 | MP0004043_abnormal_pH_regulation | 0.84286655 |
| 84 | MP0004085_abnormal_heartbeat | 0.83998822 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.83706048 |
| 86 | MP0003121_genomic_imprinting | 0.82249449 |
| 87 | MP0003632_abnormal_nervous_system | 0.79821060 |
| 88 | MP0002928_abnormal_bile_duct | 0.78415749 |
| 89 | MP0001485_abnormal_pinna_reflex | 0.77751740 |
| 90 | MP0000026_abnormal_inner_ear | 0.77456396 |
| 91 | MP0001177_atelectasis | 0.77317747 |
| 92 | MP0005195_abnormal_posterior_eye | 0.76596785 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.74849910 |
| 94 | * MP0003861_abnormal_nervous_system | 0.73948998 |
| 95 | MP0004215_abnormal_myocardial_fiber | 0.72732112 |
| 96 | MP0006072_abnormal_retinal_apoptosis | 0.72194473 |
| 97 | MP0000427_abnormal_hair_cycle | 0.68678493 |
| 98 | MP0008877_abnormal_DNA_methylation | 0.68596020 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.68325095 |
| 100 | MP0002160_abnormal_reproductive_system | 0.68114041 |
| 101 | MP0005410_abnormal_fertilization | 0.67748153 |
| 102 | MP0003283_abnormal_digestive_organ | 0.67672647 |
| 103 | MP0008872_abnormal_physiological_respon | 0.67087188 |
| 104 | MP0001943_abnormal_respiration | 0.65510131 |
| 105 | MP0003698_abnormal_male_reproductive | 0.64992174 |
| 106 | MP0008874_decreased_physiological_sensi | 0.64077251 |
| 107 | MP0000049_abnormal_middle_ear | 0.63308601 |
| 108 | MP0002938_white_spotting | 0.62928121 |
| 109 | MP0001664_abnormal_digestion | 0.61173898 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.60847862 |
| 111 | MP0002653_abnormal_ependyma_morphology | 0.60827021 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.59334701 |
| 113 | MP0005253_abnormal_eye_physiology | 0.58559389 |
| 114 | MP0004484_altered_response_of | 0.56947665 |
| 115 | MP0010770_preweaning_lethality | 0.56340237 |
| 116 | MP0002082_postnatal_lethality | 0.56340237 |
| 117 | MP0010769_abnormal_survival | 0.55575296 |
| 118 | MP0002090_abnormal_vision | 0.55215830 |
| 119 | MP0005535_abnormal_body_temperature | 0.54551894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.55562327 |
| 2 | Myokymia (HP:0002411) | 5.90851499 |
| 3 | Focal seizures (HP:0007359) | 4.87120646 |
| 4 | Atonic seizures (HP:0010819) | 4.65891166 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.45921923 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.43979020 |
| 7 | Febrile seizures (HP:0002373) | 4.27858710 |
| 8 | Visual hallucinations (HP:0002367) | 4.05037654 |
| 9 | Absence seizures (HP:0002121) | 3.57782587 |
| 10 | Hyperventilation (HP:0002883) | 3.34594187 |
| 11 | Dialeptic seizures (HP:0011146) | 3.34346047 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.32673204 |
| 13 | Action tremor (HP:0002345) | 3.30633275 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.27548303 |
| 15 | Broad-based gait (HP:0002136) | 3.26659274 |
| 16 | Ankle clonus (HP:0011448) | 3.11454506 |
| 17 | Limb dystonia (HP:0002451) | 3.06618596 |
| 18 | Abnormality of the corticospinal tract (HP:0002492) | 3.02102410 |
| 19 | Insidious onset (HP:0003587) | 3.02018465 |
| 20 | Termporal pattern (HP:0011008) | 3.02018465 |
| 21 | Gaze-evoked nystagmus (HP:0000640) | 2.97596158 |
| 22 | Pheochromocytoma (HP:0002666) | 2.95186289 |
| 23 | Molar tooth sign on MRI (HP:0002419) | 2.87253000 |
| 24 | Abnormality of midbrain morphology (HP:0002418) | 2.87253000 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.81631271 |
| 26 | Gait imbalance (HP:0002141) | 2.80380944 |
| 27 | Pancreatic fibrosis (HP:0100732) | 2.78934920 |
| 28 | Truncal ataxia (HP:0002078) | 2.78810183 |
| 29 | Nephronophthisis (HP:0000090) | 2.75973052 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.75730419 |
| 31 | Amblyopia (HP:0000646) | 2.74555392 |
| 32 | Neuroendocrine neoplasm (HP:0100634) | 2.68370374 |
| 33 | Drooling (HP:0002307) | 2.67690535 |
| 34 | Excessive salivation (HP:0003781) | 2.67690535 |
| 35 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.66184329 |
| 36 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.66184329 |
| 37 | True hermaphroditism (HP:0010459) | 2.66031341 |
| 38 | Polyphagia (HP:0002591) | 2.60707852 |
| 39 | Dysdiadochokinesis (HP:0002075) | 2.60182489 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.58326183 |
| 41 | Spastic gait (HP:0002064) | 2.55930989 |
| 42 | Pancreatic cysts (HP:0001737) | 2.54409729 |
| 43 | Dysmetria (HP:0001310) | 2.53815175 |
| 44 | Progressive inability to walk (HP:0002505) | 2.48696608 |
| 45 | Abnormal hair whorl (HP:0010721) | 2.48114554 |
| 46 | Anxiety (HP:0000739) | 2.47642447 |
| 47 | Mutism (HP:0002300) | 2.45147138 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.44860903 |
| 49 | Lissencephaly (HP:0001339) | 2.42333402 |
| 50 | Urinary urgency (HP:0000012) | 2.41770327 |
| 51 | Genetic anticipation (HP:0003743) | 2.40614668 |
| 52 | Depression (HP:0000716) | 2.38813893 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.37940291 |
| 54 | Medial flaring of the eyebrow (HP:0010747) | 2.36171622 |
| 55 | Cerebral inclusion bodies (HP:0100314) | 2.33592060 |
| 56 | Absent speech (HP:0001344) | 2.33317824 |
| 57 | Congenital primary aphakia (HP:0007707) | 2.32764157 |
| 58 | Epileptiform EEG discharges (HP:0011182) | 2.31867935 |
| 59 | Scanning speech (HP:0002168) | 2.28793364 |
| 60 | Specific learning disability (HP:0001328) | 2.27671611 |
| 61 | Poor eye contact (HP:0000817) | 2.27478853 |
| 62 | Spastic tetraplegia (HP:0002510) | 2.22959017 |
| 63 | Status epilepticus (HP:0002133) | 2.22857463 |
| 64 | Genital tract atresia (HP:0001827) | 2.22359240 |
| 65 | Diplopia (HP:0000651) | 2.21127362 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.21127362 |
| 67 | Poor coordination (HP:0002370) | 2.20811002 |
| 68 | Nephrogenic diabetes insipidus (HP:0009806) | 2.20473175 |
| 69 | Lower limb muscle weakness (HP:0007340) | 2.20153254 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18241379 |
| 71 | Abnormality of the renal medulla (HP:0100957) | 2.16578004 |
| 72 | Pachygyria (HP:0001302) | 2.15662237 |
| 73 | Vaginal atresia (HP:0000148) | 2.14839884 |
| 74 | Ulnar claw (HP:0001178) | 2.14400864 |
| 75 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.14161328 |
| 76 | Absent/shortened dynein arms (HP:0200106) | 2.14161328 |
| 77 | Abnormality of the lower motor neuron (HP:0002366) | 2.13290319 |
| 78 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.11268849 |
| 79 | Akinesia (HP:0002304) | 2.11002446 |
| 80 | Hemiparesis (HP:0001269) | 2.09047132 |
| 81 | Inability to walk (HP:0002540) | 2.08691194 |
| 82 | Hypsarrhythmia (HP:0002521) | 2.07157732 |
| 83 | Abnormal ciliary motility (HP:0012262) | 2.06906529 |
| 84 | Failure to thrive in infancy (HP:0001531) | 2.04308200 |
| 85 | Abnormal social behavior (HP:0012433) | 2.03396069 |
| 86 | Impaired social interactions (HP:0000735) | 2.03396069 |
| 87 | Type II lissencephaly (HP:0007260) | 2.03290236 |
| 88 | Retinal dysplasia (HP:0007973) | 2.02004948 |
| 89 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.00886835 |
| 90 | Optic nerve hypoplasia (HP:0000609) | 1.99853677 |
| 91 | Agitation (HP:0000713) | 1.99737515 |
| 92 | Impaired smooth pursuit (HP:0007772) | 1.99108072 |
| 93 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.98570324 |
| 94 | Hypoplasia of the brainstem (HP:0002365) | 1.98570324 |
| 95 | Oligodactyly (hands) (HP:0001180) | 1.96467345 |
| 96 | Protruding tongue (HP:0010808) | 1.96143576 |
| 97 | Blue irides (HP:0000635) | 1.94444329 |
| 98 | Amyotrophic lateral sclerosis (HP:0007354) | 1.90854942 |
| 99 | Sleep apnea (HP:0010535) | 1.90128179 |
| 100 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.89292257 |
| 101 | Cystic liver disease (HP:0006706) | 1.88943485 |
| 102 | Hypoventilation (HP:0002791) | 1.87360592 |
| 103 | Esotropia (HP:0000565) | 1.86407295 |
| 104 | Postaxial hand polydactyly (HP:0001162) | 1.86253884 |
| 105 | Bradykinesia (HP:0002067) | 1.85927979 |
| 106 | Abnormality of salivation (HP:0100755) | 1.84157812 |
| 107 | Impaired vibratory sensation (HP:0002495) | 1.83245721 |
| 108 | Postural instability (HP:0002172) | 1.83165334 |
| 109 | Narrow nasal bridge (HP:0000446) | 1.82714511 |
| 110 | Generalized myoclonic seizures (HP:0002123) | 1.80550734 |
| 111 | Torticollis (HP:0000473) | 1.79821177 |
| 112 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.79514174 |
| 113 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.79514174 |
| 114 | Poor suck (HP:0002033) | 1.78811204 |
| 115 | Chronic hepatic failure (HP:0100626) | 1.78474254 |
| 116 | Abnormality of the labia minora (HP:0012880) | 1.77280130 |
| 117 | Stereotypic behavior (HP:0000733) | 1.76432321 |
| 118 | Focal dystonia (HP:0004373) | 1.75213627 |
| 119 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.75030423 |
| 120 | Hypothermia (HP:0002045) | 1.75021927 |
| 121 | Congenital stationary night blindness (HP:0007642) | 1.71703228 |
| 122 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.71420196 |
| 123 | Sclerocornea (HP:0000647) | 1.69978730 |
| 124 | Narrow forehead (HP:0000341) | 1.69516911 |
| 125 | Hypoplasia of the corpus callosum (HP:0002079) | 1.69426510 |
| 126 | Volvulus (HP:0002580) | 1.69149539 |
| 127 | Exotropia (HP:0000577) | 1.66796212 |
| 128 | Postaxial foot polydactyly (HP:0001830) | 1.66243458 |
| 129 | Muscular hypotonia of the trunk (HP:0008936) | 1.66199323 |
| 130 | Intellectual disability, severe (HP:0010864) | 1.63148302 |
| 131 | Hepatoblastoma (HP:0002884) | 1.62484912 |
| 132 | Intention tremor (HP:0002080) | 1.59477181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.20404461 |
| 2 | NTRK3 | 4.14688461 |
| 3 | MARK1 | 3.71221242 |
| 4 | EPHA4 | 3.08551016 |
| 5 | MAP3K4 | 3.01161548 |
| 6 | MAP3K9 | 2.91522399 |
| 7 | MAP2K7 | 2.75777480 |
| 8 | MINK1 | 2.63433687 |
| 9 | FRK | 2.46965476 |
| 10 | MAP3K12 | 2.39271732 |
| 11 | PNCK | 2.23203113 |
| 12 | MAPK13 | 2.09299621 |
| 13 | NTRK2 | 2.08592744 |
| 14 | PLK2 | 1.89720591 |
| 15 | DAPK2 | 1.89542996 |
| 16 | PINK1 | 1.86428142 |
| 17 | CDK19 | 1.73944133 |
| 18 | MAP2K4 | 1.71372099 |
| 19 | NTRK1 | 1.64268615 |
| 20 | TNIK | 1.52697648 |
| 21 | PAK6 | 1.51322007 |
| 22 | TRIM28 | 1.48741925 |
| 23 | MAP4K2 | 1.44037153 |
| 24 | GRK5 | 1.41186940 |
| 25 | CDK5 | 1.37975861 |
| 26 | OXSR1 | 1.35318218 |
| 27 | PHKG1 | 1.33074447 |
| 28 | PHKG2 | 1.33074447 |
| 29 | UHMK1 | 1.31023999 |
| 30 | KSR1 | 1.26814923 |
| 31 | PRKCG | 1.22340958 |
| 32 | DAPK1 | 1.22017370 |
| 33 | SGK223 | 1.21794151 |
| 34 | SGK494 | 1.21794151 |
| 35 | ARAF | 1.20030439 |
| 36 | PRPF4B | 1.16768099 |
| 37 | KSR2 | 1.12050151 |
| 38 | * CAMK2A | 1.10719064 |
| 39 | CAMK2B | 1.10240392 |
| 40 | CSNK1G2 | 1.09463693 |
| 41 | SIK2 | 1.06855310 |
| 42 | BCR | 1.05966469 |
| 43 | RIPK4 | 1.04189597 |
| 44 | STK39 | 1.00190515 |
| 45 | FES | 0.97689484 |
| 46 | LATS2 | 0.96960436 |
| 47 | AKT3 | 0.94182067 |
| 48 | CDK14 | 0.94041210 |
| 49 | CAMKK1 | 0.93417265 |
| 50 | CDK18 | 0.93331888 |
| 51 | CDK15 | 0.88150652 |
| 52 | SGK2 | 0.88145788 |
| 53 | DYRK2 | 0.85780712 |
| 54 | LIMK1 | 0.85556972 |
| 55 | GRK7 | 0.85349660 |
| 56 | DYRK1A | 0.84350795 |
| 57 | BMPR2 | 0.80743660 |
| 58 | SIK3 | 0.80399300 |
| 59 | GRK1 | 0.79484476 |
| 60 | PRKD3 | 0.79389410 |
| 61 | PRKCE | 0.78865038 |
| 62 | CDK11A | 0.77719009 |
| 63 | CSNK1G3 | 0.77401640 |
| 64 | MKNK2 | 0.77169118 |
| 65 | PAK3 | 0.76481960 |
| 66 | CAMKK2 | 0.74267309 |
| 67 | FGFR2 | 0.73951086 |
| 68 | CAMK2D | 0.72600331 |
| 69 | MARK2 | 0.72408646 |
| 70 | PTK2B | 0.72041883 |
| 71 | INSRR | 0.71811048 |
| 72 | MAPKAPK5 | 0.69791089 |
| 73 | WNK3 | 0.69669541 |
| 74 | FER | 0.68913388 |
| 75 | PKN1 | 0.67731433 |
| 76 | TYRO3 | 0.65438575 |
| 77 | NME1 | 0.64009059 |
| 78 | ERBB3 | 0.63961916 |
| 79 | DYRK3 | 0.63705340 |
| 80 | CAMK2G | 0.60312035 |
| 81 | MAP3K2 | 0.59303877 |
| 82 | CAMK1 | 0.59226997 |
| 83 | ROCK2 | 0.58474667 |
| 84 | STK38 | 0.58378277 |
| 85 | FGR | 0.57963530 |
| 86 | STK11 | 0.56642006 |
| 87 | SGK1 | 0.56637438 |
| 88 | ADRBK1 | 0.56326777 |
| 89 | CAMK4 | 0.56216991 |
| 90 | LMTK2 | 0.55166731 |
| 91 | RET | 0.55064595 |
| 92 | CSNK1E | 0.54478846 |
| 93 | BRAF | 0.54470798 |
| 94 | CSNK1A1L | 0.54413436 |
| 95 | WNK1 | 0.52729782 |
| 96 | PRKACA | 0.50327074 |
| 97 | RPS6KA2 | 0.49458340 |
| 98 | SGK3 | 0.48760581 |
| 99 | TNK2 | 0.48428764 |
| 100 | BMPR1B | 0.48090728 |
| 101 | PRKG1 | 0.47931934 |
| 102 | CSNK1D | 0.47654683 |
| 103 | WNK4 | 0.46212515 |
| 104 | MAPK15 | 0.46012643 |
| 105 | CSNK1A1 | 0.45538082 |
| 106 | MAP3K6 | 0.45297118 |
| 107 | CAMK1G | 0.45248475 |
| 108 | NUAK1 | 0.43889227 |
| 109 | PRKCH | 0.43292193 |
| 110 | PRKCZ | 0.43057317 |
| 111 | CDK3 | 0.42149203 |
| 112 | ADRBK2 | 0.42132417 |
| 113 | EPHA3 | 0.40957205 |
| 114 | CSNK1G1 | 0.39343123 |
| 115 | MAPK10 | 0.38988633 |
| 116 | CCNB1 | 0.38781190 |
| 117 | NEK6 | 0.38668843 |
| 118 | PDK4 | 0.38075673 |
| 119 | PDK3 | 0.38075673 |
| 120 | RPS6KA3 | 0.37766037 |
| 121 | PRKACB | 0.37689819 |
| 122 | TAOK1 | 0.36079434 |
| 123 | PRKAA1 | 0.31742816 |
| 124 | PRKDC | 0.30698595 |
| 125 | EPHB2 | 0.30268047 |
| 126 | STK38L | 0.28417613 |
| 127 | GSK3B | 0.27300814 |
| 128 | RPS6KA4 | 0.27066080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.04431573 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.52350900 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75824173 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.61979933 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.57828790 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.57254616 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.49574562 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.46637380 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.44758001 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.37569426 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.26826271 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.22420320 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.10780997 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.95163841 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93592439 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.88807630 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.82018573 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.81589253 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81334860 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.74302727 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.63964068 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.62952711 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.59452265 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58787232 |
| 25 | Axon guidance_Homo sapiens_hsa04360 | 1.50907229 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.50874373 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49993781 |
| 28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.47378780 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.45822451 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45114541 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.42384506 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.39773178 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.39575905 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35993500 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.33033240 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32149632 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25241519 |
| 38 | Alzheimers disease_Homo sapiens_hsa05010 | 1.24992336 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24210662 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21368191 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12152037 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11626050 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10990593 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04358380 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 1.03318475 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02220158 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99674137 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97371829 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95886830 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90435153 |
| 51 | Huntingtons disease_Homo sapiens_hsa05016 | 0.89811298 |
| 52 | Glioma_Homo sapiens_hsa05214 | 0.89630020 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89626464 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87818311 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87738937 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86131240 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83111055 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82527275 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80705803 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79586722 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78127036 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78047374 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72622182 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69539005 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68144018 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67521285 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67372750 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66378374 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65925819 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65604645 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64830295 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64570609 |
| 73 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63934011 |
| 74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63182923 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62863500 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62832614 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61444815 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.60517679 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58360526 |
| 80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58168025 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57973331 |
| 82 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.56546275 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56211504 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55640702 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.55605898 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48786735 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48737597 |
| 88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48377497 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48150230 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45340715 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44622147 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44196325 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43719753 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43649269 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43346123 |
| 96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43340324 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42945391 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.42703880 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41949166 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41584872 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.40899588 |
| 102 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.40207934 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39248528 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39125224 |
| 105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38525055 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38400579 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36947443 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | 0.36540245 |
| 109 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35489375 |
| 110 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.35472470 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35353433 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34905737 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34173616 |
| 114 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33706411 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33436183 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32897095 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.32324820 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32118857 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31783097 |
| 120 | Melanoma_Homo sapiens_hsa05218 | 0.31428273 |
| 121 | RNA degradation_Homo sapiens_hsa03018 | 0.31180345 |
| 122 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30744729 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30527844 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29557670 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29029297 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28522936 |

